Is Vaxart Stock A Buy Ahead Of Phase 1 Data Readout?

Biotech company Vaxart's stock has rallied by about 40% over the last 5 trading days, with a bulk of the gains coming on Monday. The stock is also up by about 76% since the beginning of 2021, compared to the S&P 500 which has gained just about 3% over the same time frame. Vaxart is looking to...